SecBot SecBot
SECBOTREPLAY Home › Report › VRTX

VRTX · Seven Vertex Pharmaceuticals executives sold shares in the past week,…

VERTEX PHARMACEUTICALS INC / MA · CLUSTER filed Feb 24, 2026 at 19:00 ET

At the news

NEUTRALIMPACT 4/10

CLUSTER filed Feb 24, 2026 at 19:00 ET

Seven Vertex Pharmaceuticals executives sold shares in the past week, including open-market sales totaling $2.3M and tax-related share withholdings worth $7.3M. The activity is primarily driven by routine tax settlements following vesting events, not discretionary selling.

  • Five executives conducted open-market sales totaling $2.31M in the past two days.
  • All seven insiders also surrendered shares for tax withholding totaling $7.31M, including CEO Reshma Kewalramani ($2.42M) and Executive Chairman Jeffrey Leiden ($1.72M).
  • Tax withholdings accounted for ~76% of total transaction value in the cluster.
  • Total economic value of open-market sales is 0.0019% of VRTX's $122.5B market cap, immaterial in scale.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access